Stellate Ganglion Block for Major Depressive Disorder.

Official Title

Stellate Ganglion Block for Major Depressive Disorder: A Randomized Controlled Pilot Trial


This is a feasibility study, to investigate a new treatment option for major depressive disorders by performing a Stellate Ganglion Block (SGB). A SGB is an injection of local anesthetic into the sympathetic nervous system (peripheral nervous system) located in the lower part of the neck, to relieve pain in the head, neck, upper arm, and upper chest.

Trial Description

Primary Outcome:

  • Feasibility, Recruitment, Acceptability, Safety,
Secondary Outcome:
  • Change in the symptoms of depression

View this trial on

Interested in this trial?

Print this page and take it to your doctor to discuss your eligibilty and treatment options. Only your doctor can refer you to a clinical trial.


Canadian Cancer Society

These resources are provided in partnership with the Canadian Cancer Society